Market Place
Sourcing Support
Kiyatec Gains MBD Investment to Boost U.S. Expansion
13 Nov 2025 //
BUSINESSWIRE
Kiyatec Publishes Study On 3D Predict™ Glioma In HGG Patients
29 Aug 2024 //
BUSINESSWIRE
Kiyatec Appoints Eric Perreault as New CEO to Lead Strategic Expansion
04 Jan 2024 //
BUSINESSWIRE
Kiyatec strengthens its leadership position with the addition of Mark Capone
21 Nov 2023 //
BUSINESSWIRE
Kiyatec Appoints Eric Perreault to President and Tessa DesRochers CSO
01 Aug 2023 //
BUSINESSWIRE
Kiyatec & XenoSTART formally announce a agreement to help reduce drug devp costs
29 Jun 2023 //
BUSINESSWIRE
Kiyatec & AZ Announce a Multifaceted Research Agreement
30 May 2023 //
BUSINESSWIRE
Kiyatec Announces Investment from Brain Cancer Venture Philanthropy Funds
18 May 2023 //
BUSINESSWIRE
Kiyatec to present highlighting the company’s work in ex vivo immuno-oncology
11 Apr 2023 //
BUSINESSWIRE
Kiyatec announces Series C round with US$18M closing
12 Dec 2022 //
BUSINESSWIRE
Kiyatec to Sponsor and Exhibit at American Brain Tumor Association Conference
07 Sep 2022 //
BUSINESSWIRE
KIYATEC to Present at KeyBanc Capital Life Sciences & MedTech Investor Forum
21 Mar 2022 //
BUSINESSWIRE
KIYATEC Provides Update on Clinical Data of 3D-PREDICT clinical Study
17 Jun 2021 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.